<DOC>
	<DOC>NCT00885989</DOC>
	<brief_summary>This study will investigate the safety and tolerability of the first IV dosing of SLV338 in healthy volunteers.</brief_summary>
	<brief_title>Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>healthy not healthy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>SLV338</keyword>
	<keyword>phase I</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>